These results demonstrated that the influence of RPS14 overexpression on the phosphorylation level of Akt and development in CRC cells could be alleviated by CDK1 inhibitors, revealing that RPS14 exerted oncogenic function via PI3K-Akt signaling pathway. The gene discussed is AKT1; the disease is colorectal carcinoma.